Drug profile · INN
loxapine hydrochloride
LOXITANE C
loxapine hydrochloride (LOXITANE C) is a d2-like dopamine receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — loxapine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
loxapine hydrochloride (LOXITANE C) is a d2-like dopamine receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
D2-like dopamine receptor antagonist
Primary target: D2-like dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is loxapine hydrochloride?
loxapine hydrochloride (LOXITANE C) is a d2-like dopamine receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for loxapine hydrochloride?
LOXITANE C is a marketed brand name for loxapine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of loxapine hydrochloride?
loxapine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.